| Baveno VII–renewing consensus in portal hypertension R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ... Journal of hepatology 76 (4), 959-974, 2022 | 1371 | 2022 |
| Detection of various microplastics in human stool: a prospective case series P Schwabl, S Köppel, P Königshofer, T Bucsics, M Trauner, T Reiberger, ... Annals of internal medicine 171 (7), 453-457, 2019 | 1221 | 2019 |
| EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 1066 | 2017 |
| Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis M Mandorfer, S Bota, P Schwabl, T Bucsics, N Pfisterer, M Kruzik, ... Gastroenterology 146 (7), 1680-1690. e1, 2014 | 476 | 2014 |
| CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice Y Chen, RR Ramjiawan, T Reiberger, MR Ng, T Hato, Y Huang, H Ochiai, ... Hepatology 61 (5), 1591-1602, 2015 | 418 | 2015 |
| Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol T Reiberger, G Ulbrich, A Ferlitsch, BA Payer, P Schwabl, M Pinter, ... Gut 62 (11), 1634-1641, 2013 | 406 | 2013 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 340 | 2020 |
| Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis T Reiberger, A Ferlitsch, BA Payer, M Mandorfer, BB Heinisch, H Hayden, ... Journal of hepatology 58 (5), 911-921, 2013 | 331 | 2013 |
| Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension M Mandorfer, K Kozbial, P Schwabl, C Freissmuth, R Schwarzer, R Stern, ... Journal of hepatology 65 (4), 692-699, 2016 | 301 | 2016 |
| von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis M Ferlitsch, T Reiberger, M Hoke, P Salzl, B Schwengerer, G Ulbrich, ... Hepatology 56 (4), 1439-1447, 2012 | 216 | 2012 |
| Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis M Simón-Talero, D Roccarina, J Martínez, K Lampichler, A Baiges, G Low, ... Gastroenterology 154 (6), 1694-1705. e4, 2018 | 207 | 2018 |
| Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal‐derived factor 1 alpha/C‐X‐C receptor type 4 axis and myeloid differentiation antigen … Y Chen, Y Huang, T Reiberger, AM Duyverman, P Huang, R Samuel, ... Hepatology 59 (4), 1435-1447, 2014 | 206 | 2014 |
| PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 74 (5), 1097-1108, 2021 | 188 | 2021 |
| The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction P Schwabl, E Hambruch, BA Seeland, H Hayden, M Wagner, L Garnys, ... Journal of hepatology 66 (4), 724-733, 2017 | 166 | 2017 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
| Beta adrenergic blockade and decompensated cirrhosis T Reiberger, M Mandorfer Journal of hepatology 66 (4), 849-859, 2017 | 164 | 2017 |
| Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma N Rohr-Udilova, F Klinglmueller, R Schulte-Hermann, J Stift, M Herac, ... Scientific reports 8 (1), 6220, 2018 | 163 | 2018 |
| Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III) T Reiberger, A Püspök, M Schoder, F Baumann-Durchschein, T Bucsics, ... Wiener klinische Wochenschrift 129 (Suppl 3), 135-158, 2017 | 162 | 2017 |
| Prognosis of patients with hepatocellular carcinoma treated with immunotherapy–development and validation of the CRAFITY score B Scheiner, K Pomej, MM Kirstein, F Hucke, F Finkelmeier, O Waidmann, ... Journal of hepatology 76 (2), 353-363, 2022 | 150 | 2022 |
| Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease M Pons, S Augustin, B Scheiner, M Guillaume, M Rosselli, SG Rodrigues, ... Official journal of the American College of Gastroenterology| ACG 116 (4 …, 2021 | 137 | 2021 |
Mattias MandorferMedical University of ViennaVerified email at meduniwien.ac.at
